J.-M. Le Mellédo

University of Alberta — Canada

Medicine · Health Sciences

5h-index46citations18works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac Health and Mental Health(4), Menstrual Health and Disorders(4), Neuropeptides and Animal Physiology(3), Receptor Mechanisms and Signaling(2), Neuroendocrine regulation and behavior(2)

Publications18 total

A101 VIRTUAL MINDFULNESS-BASED STRESS REDUCTION FOR ADULTS WITH INFLAMMATORY BOWEL DISEASE: FEASIBILITY TRIAL PRELIMINARY RESULTS
Journal of the Canadian Association of Gastroenterology·2023Open Access
Glutamate levels in the medial prefrontal cortex of healthy pregnant women compared to non-pregnant controls
Psychoneuroendocrinology·2021· 5 cited
Dysregulation of the nitric oxide pathway as a risk factor for increased cardiovascular risk in patients with major depression
European Neuropsychopharmacology·2019· 1 cited
Glutamate levels in the medial prefrontal cortex during pregnancy
European Neuropsychopharmacology·2017
Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol
Journal of Psychopharmacology·2009· 7 cited
Do Patients Follow-Up with Discharge Advice After Psychiatric Assessment and Discharge from Emergency Department?
European Psychiatry·2009Open Access
Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
Circulation·2004· 5 citedOpen Access
Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptide
Peptides·2001· 15 cited
273. Hostility and associated cholesterol levels in panic disorder patients
Biological Psychiatry·2000
303. Response to flumazenil in women with premenstrual dysphoric disorder
Biological Psychiatry·1998· 6 cited
337. The influence of pretreatment with medroxyprogesterone on the response to pentagastrin
Biological Psychiatry·1998
Influence of type A behaviour pattern on response to CCK-4
Biological Psychiatry·1997
The effects of CCK-4 in normal individuals: Comparison of panickers and nonpanickers
European Neuropsychopharmacology·1996· 2 cited
Effect of a major depressive episode history on the CCK-4 response in women
European Neuropsychopharmacology·1996
The role of the seta adrenergic system in CCK-4 induced panic symptoms
European Neuropsychopharmacology·1996· 2 cited
P-1-5 Enhanced sensitivity to CCK-4 in women with severe premenstrual symptoms (PDD)
European Neuropsychopharmacology·1995
P-1-4 The effects of CCK-4 on plasma arginine-vasopressin and oxytocin levels in women with and without premenstrual dysphoric disorder
European Neuropsychopharmacology·1995· 2 cited
Pharmacology of cholecystokinin agonists and antagonists
European Neuropsychopharmacology·1992· 1 cited

Frequent Co-authors

Jacques Bradwejn(7), Diana Koszycki(7), F. Bellavance(6), Daniel G. Bichet(6), Karen McManus(2), Gian S. Jhangri(2), Darrin L. Bailey(2), Glen B. Baker(2), Alyssa M McEwen(2), Christopher C. Hanstock(2), Peter Seres(2), Panteha Khalili(2), Stacy Steinberg(2), Uriel Halbreich(2), Jack Legrand(2), Jorge Perez-Parada(1), Jarret Morrow(1), François Bellavance(1), Nathalie Lara(1), Farideh Jahandar(1)